Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDXORTX Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.69 | -$0.69 | -$0.69 |
| Q2 2024 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q1 2025 | 1 | -$0.36 | -$0.36 | -$0.36 |
| Q2 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
XORTX Therapeutics Inc. Earnings Date And Information
XORTX Therapeutics Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.2 earnings per share for the quarter, topping analysts' consensus estimates of $-0.38313 by $0.18313. The company had revenue of 0 for the quarter and had revenue of 0 for the year. XORTX Therapeutics Inc. has generated $-1 earnings per share over the last year ($-1.08 diluted earnings per share) and currently has a price-to-earnings ratio of -3.49. XORTX Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based on prior year's report dates.
XORTX Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/15/2024 | Q3 2024 | -$0.20 | $0 | $0 | ||
| 06/29/2024 | Q2 2024 | $0.07 | $0 | $0 | ||
| 03/30/2024 | Q1 2024 | -$1.24 | $0 | |||
| 12/30/2023 | Q4 2023 | $1.22 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.67 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.85 | $0 | |||
| 03/30/2023 | Q1 2023 | -$1.31 | -$0.95 | 0.36 | $0 | |
| 12/30/2022 | Q4 2022 | -$2.18 | -$1.80 | 0.38 | $0 | |
| 09/29/2022 | Q3 2022 | -$1.08 | $0 | |||
| 06/29/2022 | Q2 2022 | -$1.10 | $0 | |||
| 03/30/2022 | Q1 2022 | -$2.38 | $0 | |||
| 12/30/2021 | Q4 2021 | $6.30 | $0 | |||
| 09/29/2021 | Q3 2021 | -$8.03 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.21 | $0 | |||
| 03/30/2021 | Q1 2021 | -$2.39 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.59 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.55 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.49 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.05 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.32 | $0 |
XORTX Therapeutics Inc. Earnings: FAQ's
When is XORTX Therapeutics Inc.'s earnings date?
XORTX Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based off last year's report dates.
Did XORTX Therapeutics Inc. beat their earnings estimates last
quarter?
In the previous quarter, XORTX Therapeutics Inc. (:XRTX) reported $-0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.38313 by $0.18313.
How can I listen to XORTX Therapeutics Inc.'s earnings conference
call?
The conference call for XORTX Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read XORTX Therapeutics Inc.'s conference call transcript?
The conference call transcript for XORTX Therapeutics Inc.'s latest earnings report can be read online.
How much profit does XORTX Therapeutics Inc. generate each year?
XORTX Therapeutics Inc. (:XRTX) has a recorded net income of $0. XORTX Therapeutics Inc. has generated $-1.08 earnings per share over the last four quarters.
What is XORTX Therapeutics Inc.'s price-to-earnings ratio?
XORTX Therapeutics Inc. (:XRTX) has a price-to-earnings ratio of -3.49 and price/earnings-to-growth ratio is -0.03.